KEAP1 and chronic kidney disease: In the remnant kidney tissue of rat CKD model Nrf2 activity (nuclear translocation) was mildly reduced at 6 weeks and markedly reduced at 12 weeks, whereas the Nrf2 repressor Keap1 was up-regulated and the products of Nrf2 target genes were significantly diminished at 12 weeks [42].